FI903213A0 - Foer transdermal administration avsett gestoden innehaollande medel. - Google Patents

Foer transdermal administration avsett gestoden innehaollande medel.

Info

Publication number
FI903213A0
FI903213A0 FI903213A FI903213A FI903213A0 FI 903213 A0 FI903213 A0 FI 903213A0 FI 903213 A FI903213 A FI 903213A FI 903213 A FI903213 A FI 903213A FI 903213 A0 FI903213 A0 FI 903213A0
Authority
FI
Finland
Prior art keywords
innehaollande
foer
medel
gestodene
intended
Prior art date
Application number
FI903213A
Other languages
English (en)
Other versions
FI100456B (fi
Inventor
Clemens Guenther
Ulrich Taeuber
Karin Schmidt-Gollwitzer
Jutta Riedl
Johannes-Wilhelm Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE3836862 priority Critical
Priority to DE19883836862 priority patent/DE3836862A1/de
Priority to DE3910578 priority
Priority to DE19893910578 priority patent/DE3910578A1/de
Priority to PCT/EP1989/001200 priority patent/WO1990004397A1/de
Priority to EP8901200 priority
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI903213A0 publication Critical patent/FI903213A0/fi
Application granted granted Critical
Publication of FI100456B publication Critical patent/FI100456B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
FI903213A 1988-10-27 1990-06-26 Gestodeenia sisältävän vaikuttavan aineen transdermaaliseen antoon tar koitetun välineen käyttö raskauden ehkäisyyn FI100456B (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE3836862 1988-10-27
DE19883836862 DE3836862A1 (de) 1988-10-27 1988-10-27 Mittel zur transdermalen applikation von steroidhormonen
DE3910578 1989-03-29
DE19893910578 DE3910578A1 (de) 1989-03-29 1989-03-29 Mittel zur transdermalen applikation enthaltend gestoden
PCT/EP1989/001200 WO1990004397A1 (de) 1988-10-27 1989-10-11 Mittel zur transdermalen applikation enthaltend gestoden
EP8901200 1989-10-11

Publications (2)

Publication Number Publication Date
FI903213A0 true FI903213A0 (fi) 1990-06-26
FI100456B FI100456B (fi) 1997-12-15

Family

ID=25873728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903213A FI100456B (fi) 1988-10-27 1990-06-26 Gestodeenia sisältävän vaikuttavan aineen transdermaaliseen antoon tar koitetun välineen käyttö raskauden ehkäisyyn

Country Status (20)

Country Link
US (1) US5788984A (fi)
EP (3) EP0370220B1 (fi)
JP (1) JP3238389B2 (fi)
KR (1) KR0137463B1 (fi)
CN (2) CN1036836C (fi)
AT (1) AT132751T (fi)
AU (3) AU4374789A (fi)
CA (1) CA2001618C (fi)
DE (1) DE58909570D1 (fi)
DK (1) DK175804B1 (fi)
ES (1) ES2081823T3 (fi)
FI (1) FI100456B (fi)
GR (1) GR3019079T3 (fi)
HU (1) HU210549B (fi)
IE (1) IE81077B1 (fi)
IL (1) IL92007A (fi)
MX (1) MX173621B (fi)
NO (1) NO180567C (fi)
PT (1) PT92131B (fi)
WO (1) WO1990004397A1 (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2625254B2 (ja) * 1990-06-01 1997-07-02 ザ ポピュレイション カウンスル St1435の治療有効局所施用
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
NZ240358A (en) * 1990-10-29 1994-09-27 Alza Corp Transdermal contraceptive device comprising (as active agents) an estrogen and a gestodene together with a skin permeation enhancer
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5320850A (en) * 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
JPH07504672A (fi) * 1992-03-21 1995-05-25 Entec
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
JPH09510697A (ja) * 1994-01-27 1997-10-28 シエーリング アクチエンゲゼルシヤフト 14α,17α−エタノエストラ−1,3,5(10)−トリエン−3,17β−ジオールを含有する経皮投与のための薬剤
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
KR100215027B1 (ko) * 1997-01-27 1999-08-16 성재갑 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
FR2772270B1 (fr) * 1997-12-15 2002-06-07 Besins Iscovesco Lab Utilisation d'un oestrogene pour le traitement de la depression postnatale
AU1728099A (en) 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
US20040202710A1 (en) * 1999-07-02 2004-10-14 Walter Muller Microreservoir system based on polysiloxanes and ambiphilic solvents
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
FR2848112B1 (fr) * 2002-12-10 2007-02-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
FR2851470B1 (fr) 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
MXPA05008778A (es) 2003-02-21 2006-05-25 Schering Ag Emplaste transdermico estable a uv.
US7858607B2 (en) 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
US7879357B2 (en) 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050129756A1 (en) * 2003-12-10 2005-06-16 Hans-Peter Podhaisky UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
MXPA06006682A (es) * 2003-12-12 2006-08-11 Schering Ag Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
JO2606B1 (en) 2003-12-12 2011-11-01 باير شيرنج فارما اكتنجيسيلشافت Transdermal Delivery of Hormones without the need of Penetration Enhancers
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US20050222106A1 (en) * 2004-04-01 2005-10-06 Stefan Bracht Drospirenone-containing preparations for transdermal use
US20070231373A1 (en) * 2004-04-28 2007-10-04 Hunter-Fleming Limited Transdermal Steriod for Formulation
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US20110086086A1 (en) * 2005-07-26 2011-04-14 Pfizer Inc Transdermal system for varenicline
ES2693745T3 (es) 2005-10-12 2018-12-13 Unimed Pharmaceuticals, Llc Gel de testosterona mejorado para su uso en el tratamiento del hipogonadismo
EP2613772B1 (en) 2010-09-06 2016-12-14 Bayer Intellectual Property GmbH Low-dose transdermal patches with high drug release
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US20150133421A1 (en) 2012-11-21 2015-05-14 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2014006256A (es) 2011-11-23 2014-10-24 Therapeuticsmd Inc Formulaciones y terapias de reemplazo hormonal de combinacion naturales.
MX2014015900A (es) 2012-06-18 2015-07-17 Therapeuticsmd Inc Formulaciones de progesterona.
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20150045335A1 (en) 2013-01-25 2015-02-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositons and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US20170216310A1 (en) 2014-10-22 2017-08-03 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3333240A1 (de) 1983-09-12 1985-03-28 Schering Ag Mittel zur transdermalen applikation von arzneimittelwirkstoffen
FI83087C (fi) 1984-05-16 1991-05-27 Schering Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara estriol-3,17-diestrar.
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
DE3511587A1 (de) * 1985-03-27 1986-10-02 Schering Ag Glykoester des estradiols und estriols
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
CH674618A5 (fi) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5422119A (en) * 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
FR2717689B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
DK138590A (da) 1990-06-06
DE58909570D1 (de) 1996-02-22
NO902840D0 (no) 1990-06-26
DK138590D0 (da) 1990-06-06
KR0137463B1 (ko) 1998-06-01
FI903213D0 (fi)
PT92131A (pt) 1990-04-30
EP0394429B1 (de) 1996-01-10
NO902840L (no) 1990-06-26
US5788984A (en) 1998-08-04
AU4374789A (en) 1990-05-03
PT92131B (pt) 1995-06-30
WO1990004397A1 (de) 1990-05-03
AU3001192A (en) 1993-02-11
NO180567C (no) 1997-05-14
EP0370220A1 (de) 1990-05-30
FI100456B (fi) 1997-12-15
IL92007A (en) 1995-12-08
GR3019079T3 (en) 1996-05-31
AT132751T (de) 1996-01-15
IL92007D0 (en) 1990-07-12
AU2059695A (en) 1995-08-31
CN1036836C (zh) 1997-12-31
CN1157719A (zh) 1997-08-27
CN1069829C (zh) 2001-08-22
EP0394429A1 (de) 1990-10-31
ES2081823T3 (es) 1996-03-16
IE893376L (en) 1990-04-27
KR900005969A (ko) 1990-05-07
CA2001618A1 (en) 1990-04-27
NO180567B (no) 1997-02-03
CN1042075A (zh) 1990-05-16
CA2001618C (en) 2000-06-20
IE81077B1 (en) 2000-02-23
JPH03502700A (fi) 1991-06-20
FI100456B1 (fi)
EP0573133A1 (de) 1993-12-08
HU896546D0 (en) 1990-12-28
MX173621B (es) 1994-03-18
EP0370220B1 (de) 1996-01-10
DK175804B1 (da) 2005-03-07
HU210549B (en) 1995-05-29
JP3238389B2 (ja) 2001-12-10

Similar Documents

Publication Publication Date Title
DE3751121D1 (de) Gerät zur transkutanen Verabreichung von Heilmitteln.
DE68912814T2 (de) Spritzen.
DE3854068T2 (de) Pharmazeutisch aktive Bestandteile enthaltende Adhesivpflaster.
DE68909906D1 (de) Einwegspritze.
DE68915291T2 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
DK7687A (da) Injektionssproejte til engangsbrug
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
AT70195T (de) Dosierungsspritze.
FI895432A0 (fi) Foerfarande foer blandning av polymerer under deras framstaellning.
SE467521B (sv) Foerfylld spruta
AT72403T (de) Kanuele.
SE466789B (sv) Icke- aateranvaendbar spruta
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
AT36809T (de) Transdermale arzneimittelform.
DE3885018D1 (de) Injektionsspritze.
DE59006506D1 (de) Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol.
NO902840L (no) Middel for transdermal applikasjon som inneholder gestoden
FI871750A (fi) Nasal administration av laekemedel.
DE3751872D1 (de) Implantierbarer Medikamentenspeicher
FI890719A0 (fi) Foerhindrande av nedsmutsning foerorsakad av marinorganismer.
DE3781928D1 (de) Arzneimittel mit verzoegerter freisetzung.
NO883345L (no) Antimikrobielt virksomme aromatiserte tilberedninger.
NL195004B (nl) Fenylcarbamaat bevattend farmaceutisch preparaat.
BR8902517A (pt) Ampola
AT72760T (de) Transdermales therapeutisches system.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SCHERING AKTIENGESELLSCHAFT